DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 6,818,234 B1 Nair Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 6,818,234 B1 Nair Et Al USOO6818234B1 (12) United States Patent (10) Patent No.: US 6,818,234 B1 Nair et al. (45) Date of Patent: Nov. 16, 2004 (54) DIETARY FOOD SUPPLEMENT (58) Field of Search ................................. 424/725, 732, CONTAINING NATURAL 424/777; 514/816 CYCLOOXYGENASE INHIBITORS AND METHODS FOR INHIBITING PAN AND (56) References Cited NFLAMMATION FOREIGN PATENT DOCUMENTS (75) Inventors: Muraleedharan G. Nair, Okemos, MI JP O7101836 * 4/1995 (US); Haibo Wang, Fresno, CA (US); RO 113712 * 10/1998 David L. Dewitt, Okemos, MI (US); David W. Krempin, Temecula, CA OTHER PUBLICATIONS (US); Dipak K. Mody, Temecula, CA Hirschhorn, H. The Home Herbal Doctor. 1982. Publ: Perker (US); Yong Qian, San Diego, CA (US); Publishing Co., Inc. NY; pp. 52-53.* David G. Groh, Temecula, CA (US); Internet publication titled “Sanbucol Black Elderberry Audra J. Davies, Long Beach, CA Extract. The Original Nature Way” at www.betterlife.com; (US); Mary A. Murray, Irvine, CA first published on internet in 1996, 2 pages.* (US); Robin Dykhouse, Newport Internet publication titled “Elixir of Elderberry” at http:// Beach, CA (US); Marc Lemay, Long www.mothernature.com; first published on internet in 1995, Beach, CA (US) 2 pages. * Internet publication titled “Sambucol Black Elderberry” at (73) Assignees: Access Business Group International http://www.mothernature.com; first published on internet in LLC, Ada, MI (US); Michigan State 1995, 2 pages.* University, East Lansing, MI (US) Keville, K. Vegetarian times. 1990. No. 154, pp. 62-65.* (*) Notice: Subject to any disclaimer,- the term of this Brown, Jr., T. Tom Brown's Guide to Wild Edible and patent is extended or adjusted under 35 Medicinal Plants. 1985. Publ: Berkely Brooks, NY; pp. U.S.C. 154(b) by 0 days. 114-117. * cited by examiner (21) Appl. No.: 10/084,575 Primary Examiner-Christopher R. Tate (22) Filed: Feb. 27, 2002 (74) Attorney, Agent, or Firm-Lynn Schwenning Alticor Inc. Related U.S. Application Data (57) ABSTRACT (63) Continuation-in-part of application No. PCT/US00/23423, filed on Aug. 25, 2000. The present invention describes food Supplements that con (60) Provisional application No. 60/151,280, filed on Aug. 27, tain one or more fruit extracts useful for pain relief and 1999, and provisional application No. 60/151.278, filed on anti-inflammation. The food Supplements may be used to Aug. 27, 1999. inhibit inflammation mediated by cyclooxygenase and more (51) Int. Cl. ................................................ A61K 35/78 particularly by cyclooxygenase-2. (52) U.S. Cl. ....................... 424/777; 424/732; 424/725; 514/816 15 Claims, 5 Drawing Sheets U.S. Patent Nov. 16, 2004 Sheet 1 of 5 US 6,818,234 B1 1 PLANT SOURCE 3 EXTRACTANT 6 2 DFTRATE RETENTATE 20 PERMEATE 9. 5 10 DFLTRATE REVERSE OSMOSIS PARMEATE part visios RETENATE 8 SO 40 CONCENTRATE POWDER 2 11 Fig. 1 U.S. Patent Nov. 16, 2004 Sheet 2 of 5 US 6,818,234 B1 VISUAL ANALOGUESCALE PAIN RATING BEFORE AND AFTER ONE OR TWO TABLETS BERRY BLEND MEANSESE >- 5 to-ONE TABLET HTWO TABLET ZA 4 Z 3 Z 2 S - BEFORE AFTER Fig.2 PERCEN PAN RELEF AFTER ONE OR TWO TABLETS BERRY BLEND MEANSSE 100 75 Z 5 SO p 25 O ONE TABLE TWO TABLET Fig. 3 U.S. Patent Nov. 16, 2004 Sheet 3 of 5 US 6,818,234 B1 BREAKDOWN OF PAN EPISODES BYTYPE s: 30 20 L 10 O O s HEADACHE JONAMUSCULAR DYSMENORRHEA OTHER PANTYPES Fig. 4 TIMEO EFFECT AND OVERALL RAING BY DOSE LEVEL (MEANS WITH 95% C.I.) *p=.04 60 VERY GOOD 9 60 min GOOD SE O 45 mi s D g h FAR g 30 min I G 5 min POOR ONE TABLET TWO TABLETS ONEABLET TWO TABLETS TIME TO EFFECT OVERALL RATING Fig.5 U.S. Patent Nov. 16, 2004 Sheet 4 of 5 US 6,818,234 B1 SUCROSE PERMEABILITY FOLLOWING BUPROFENAND BERRYBLEND p=.04 on 100 E C 75 Sg 50 g Fig.6 2 25 f C O BUPROFEN BERRY BLEND EDERBERRY DiODE ARRAY O 254 % O OODE ARRAY 10 e 330 % f O DODE ARRAY O b A c 520 % d O SCAN ES + 10 BP % O TIME 0.00 5.00 0.00 5.00 20.00 25.00 3O.OO 35.00 Fig. 7 U.S. Patent Nov. 16, 2004 Sheet 5 of 5 US 6,818,234 B1 BERRY BLEND 100 DODE ARRAY 254 O I-1- OO DODEARRAY 330 % OL--- 100 DODE ARRAY b A c 520 96 O a d OO SCAN ES BP 96 O TME O.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00 Fig.8 US 6,818,234 B1 1 2 DETARY FOOD SUPPLEMENT composition for use in relieving or alleviating pain, CONTAINING NATURAL inflammation, and the Symptoms associated with these con CYCLOOXYGENASE INHIBITORS AND ditions. In addition, there is a need for a natural composition METHODS FOR INHIBITING PAIN AND that provides relief from pain and inflammation with mini NFLAMMATION mal Side effects to the gastrointestinal System. The present invention addresses that need by providing a dietary food RELATED APPLICATIONS Supplement containing an extract from one or more The present application is a continuation-in-part of PCT anthocyanin-containing plants having a native active frac application Ser. No. PCT/US00/23423 filed Aug. 25, 2000, tion that provides pain relief, anti-inflammation activity, of U.S. Provisional Application Ser. No. 60/151,280 filed and/or preferential COX-2 inhibition. The Supplement con Aug. 27, 1999 and U.S. Provisional Application Ser. No. tains an amount of the fraction in a proportion by dry weight 60/151,278 filed Aug. 27, 1999, all of which are herein of other components that Significantly exceeds a proportion incorporated by reference. of the fraction present by dry weight in juice obtained from the plant material. In general, the active fraction includes BACKGROUND 15 flavonoids, and in particular, anthocyanins. The present invention relates to dietary food Supplements Unless otherwise Specifically Stated, all percentages used that are useful for the relief of pain or inflammation, and also in the Specification and claims are weight percentages. for the inhibition of biochemical pathways related to pain or inflammation transmission. These food Supplements contain BRIEF DESCRIPTION OF THE DRAWING flavonoids, and more particularly, certain anthocyanins. FIG. 1 shows a flow sheet of one embodiment of a process Today, many consumerS Seek natural alternatives to Syn for obtaining and concentrating desirable anthocyanins from thetic pharmaceutical products to aid with a variety of anthocyanin-containing plants. ailments experienced during daily life. Thus, dietary food FIG. 2 is a visual analogue Scale rating pain intensity Supplements containing natural Substances Such as St. Johns 25 before and after taking one or two tablets of a berry blend wort, gingko biloba, ginseng, and others have recently been Supplement in accordance with the present invention and marketed for a variety of purposes. To date, however, it is Example 7. believed that no product containing natural Substances is available to provide for the relief of pain and/or inflamma FIG.3 shows the percentage of pain relief after taking one tion equivalent to non-Steroidal anti-inflammatory drugs or two tablets of a berry blend Supplement in accordance (“NSAIDs"). with the present invention and Example 7. At the present, pain and inflammation are commonly FIG. 4 shows the breakdown of pain episodes by types for treated by the use of aspirin, ibuprofen (Motrin(R), Advil(R), the clinical trial described in Example 7. and other similar substances commonly known as NSAIDs. FIG. 5 shows the time to effect pain relief and the overall Inflammation is transmitted, in part, by a class of com 35 rating of one or two tablets of a berry blend Supplement in pounds known as prostaglandins, which are released by a accordance with the present invention and Example 7. host in response to mechanical, thermal, chemical, bacterial, FIG. 6 shows the comparative Sucrose permeability of and other insults (Moncada et al., Handbook of Exp. Pharm. ibuprofin and a berry blend Supplement in accordance with Vol 50-1, Springer Verlag, pp 588-616, 1978; Samuelsson, the present invention and Example 7. Science, 220: 568-575, 1983; Davies et al, Ann. Rev. 40 Immunol. 2:335-357, 1984). Prostaglandin synthesis is DETAILED DESCRIPTION OF THE accomplished in a stepwise manner by a ubiquitous complex INVENTION of microSomal enzymes. The first enzyme in this biosyn Prostaglandins (which include PGE, PGD, PGF, PGI thetic pathway is prostaglandin endoperoxide Synthase. This and other related compounds) represent a diverse group of enzyme also is referred to in the art as fatty acid cyclooxy 45 autocrine and paracrine hormones that are derived from the genase. There are two isoforms of this enzyme known as metabolism of fatty acids. They belong to a family of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX naturally occurring eicosanoids (prostaglandins, thrombox 2), respectively (Smith, Am. J. Physiol., 268:F181-F191, anes and leukotrienes) that are not stored as Such in cells, but 1992). are biosynthesized on demand from arachidonic acid, a Although Substances Such as aspirin inhibit prostaglandin 50 20-carbon fatty acid that is derived from the breakdown of production and thus, pain and/or inflammation, they may cell-membrane phospholipids. Under normal circumstances, cause Stomach problems and or ulcers. To address these the eicosanoids are produced at low levels to Serve as problems, drugs have been developed to target Specific pain important mediators of many and diverse cellular functions pathways in the hope that Some of the problems associated which can be very different in different types of cells. The with aspirin, ibuprofen, and other similar Substances will be 55 prostaglandins, however, also play critical roles in patho reduced if not completely eliminated.
Load more

Recommended publications
  • RP HPLC Determination of Some Uncommon Anthocyanins
    360 УДК 543.54:547.814.5 RP HPLC determination of some uncommon anthocyanins Deineka V.I., Vu Thi Ngoc Anh, Deineka L.A. Federal State Autonomous Educational Institution of Higher Professional Education «Belgorod National Research University» RF, Belgorod Received 12.02.2014 Abstract Anthocyanins of Catharanthus roseus petals were found to be composed of pairs (3-galactosides and 3-rhamnosylgalactosides) mainly of 7-methylated anthocyanidins of “dephinidin series” (7-methyldelphinidin, 7-methylpetunidin and hirsutidin); though the same derivatives of “cyanidin series” are present in low concentrations. Flowers of Caesalpinia pulcherrima contain two 3-glucosides: of cyanidin and 5-methylcyanidin. The migration of CH 3-radical from 3’-OH group to 7-OH position results in increase of retention, while for the migration to 5-OH group a decrease of retention was observed. Different position of ring A OH-groups methylation can be predicted also by controversial shift of λmax of the solutes. Keywords: Reversed-phase HPLC, uncommon anthocyanins, 7-OH methylation; 5-OH methylation; regularities of retention alteration, electronic spectra . Установлено , что антоцианы лепестков цветков Catharanthus roseus образованы парами (3-галактозидами и 3-рамнозилгалактазидами ) в-основном антоцианидинами дельфинидинового ряда с метилированием OH-группы в положении 7: 7-метилдельфинидином , 7-метилпетунидином и 7- метилмальвидином ( хирсутидином ); впрочем , аналогичные производные антоцианов цианидинового ряда также присутствуют , но в небольших концентрациях . Антоцианы высушенных цветков Caesalpiniapulcherrima содержат два 3-глюкозида : цианидина и 5-метилцианидина . Перемещение CH 3-радикала из 3’-OH группы к 7-OH группе сказывается в заметном увеличении удерживания , но при аналогичном переносе на ОН -группу в положение 5 наблюдается уменьшение удерживания . Различный тип метилирования ОН -групп кольца А приводит к противоположным смещениям λmax антоцианов .
    [Show full text]
  • Chemistry and Pharmacology of Kinkéliba (Combretum
    CHEMISTRY AND PHARMACOLOGY OF KINKÉLIBA (COMBRETUM MICRANTHUM), A WEST AFRICAN MEDICINAL PLANT By CARA RENAE WELCH A Dissertation submitted to the Graduate School-New Brunswick Rutgers, The State University of New Jersey in partial fulfillment of the requirements for the degree of Doctor of Philosophy Graduate Program in Medicinal Chemistry written under the direction of Dr. James E. Simon and approved by ______________________________ ______________________________ ______________________________ ______________________________ New Brunswick, New Jersey January, 2010 ABSTRACT OF THE DISSERTATION Chemistry and Pharmacology of Kinkéliba (Combretum micranthum), a West African Medicinal Plant by CARA RENAE WELCH Dissertation Director: James E. Simon Kinkéliba (Combretum micranthum, Fam. Combretaceae) is an undomesticated shrub species of western Africa and is one of the most popular traditional bush teas of Senegal. The herbal beverage is traditionally used for weight loss, digestion, as a diuretic and mild antibiotic, and to relieve pain. The fresh leaves are used to treat malarial fever. Leaf extracts, the most biologically active plant tissue relative to stem, bark and roots, were screened for antioxidant capacity, measuring the removal of a radical by UV/VIS spectrophotometry, anti-inflammatory activity, measuring inducible nitric oxide synthase (iNOS) in RAW 264.7 macrophage cells, and glucose-lowering activity, measuring phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression in an H4IIE rat hepatoma cell line. Radical oxygen scavenging activity, or antioxidant capacity, was utilized for initially directing the fractionation; highlighted subfractions and isolated compounds were subsequently tested for anti-inflammatory and glucose-lowering activities. The ethyl acetate and n-butanol fractions of the crude leaf extract were fractionated leading to the isolation and identification of a number of polyphenolic ii compounds.
    [Show full text]
  • WO 2017/050853 Al 30 March 2017 (30.03.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/050853 Al 30 March 2017 (30.03.2017) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C12P 19/44 (2006.01) C12N 15/52 (2006.01) kind of national protection available): AE, AG, AL, AM, C12P 17/06 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) Number: International Application DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP20 16/072474 HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (22) International Filing Date: KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 2 1 September 2016 (21 .09.201 6) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (25) Filing Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, (26) Publication Language: English TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 62/222,919 24 September 2015 (24.09.2015) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant: EVOLVA SA [CH/CH]; Duggingerstrasse 23, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 4153 Reinach (CH).
    [Show full text]
  • EEE M W 24B 24A 27B 27A N Patent Application Publication Dec
    US 2009031 1494A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0311494 A1 YAMASHTA et al. (43) Pub. Date: Dec. 17, 2009 (54) RELIEF PRINTING PLATE PRECURSOR FOR (30) Foreign Application Priority Data LASER ENGRAVING, RELIEF PRINTING PLATE, AND PROCESS FOR PRODUCING Jun. 17, 2008 (JP) ................................. 2008-157907 RELEF PRINTING PLATE Feb. 10, 2009 (JP) ................................. 2009-028816 (75) Inventors: Masako YAMASHITA, Publication Classification Shizuoka-ken (JP); Atsushi (51) Int. Cl. SUGASAKI, Shizuoka-ken (JP) B32B 3/00 (2006.01) Correspondence Address: GO3F 7/20 (2006.01) Moss & Burke, PLLC GO3F 7/004 (2006.01) 401 Holland Lane, Suite 407 Alexandria, VA 22314 (US) (52) U.S. Cl. .................... 428/195.1: 430/306: 430/286.1 (73) Assignee: FUJIFILM CORPORATION, (57) ABSTRACT Tokyo (JP) A relief printing plate precursor for laser engraving, including (21) Appl. No.: 12/476,260 a relief forming layer containing (A) a polymerizable com pound having an ethylenic unsaturated bond. (B) a binder (22) Filed: Jun. 2, 2009 polymer, and (C) a compound having deodorizing ability. 11 50 FA - 42 SUB SCANNING DIRECTION -10 - 228 7.s 55 21B EEE m w 24B 24A 27B 27A N Patent Application Publication Dec. 17, 2009 US 2009/0311494 A1 F.G. 1 FA SCANNING DIRECTION 7OA a. CSy ra & 5A - 27WSNS AD 23Ar S3EEASEE21 E-25sagaa EEEEEEEEEEEEEEEEEEEEEEEEE-22s awslighlights fskillsw. 21B 2 TTT "TT". US 2009/031 1494 A1 Dec. 17, 2009 RELEF PRINTING PLATE PRECURSORFOR mask to develop and remove an uncured area, and there is LASER ENGRAVING, RELIEF PRINTING room for improvement since development treatment is nec PLATE, AND PROCESS FOR PRODUCING essary.
    [Show full text]
  • ABSTRACT YUZUAK, SEYIT. Utilizing Metabolomics and Model Systems
    ABSTRACT YUZUAK, SEYIT. Utilizing Metabolomics and Model Systems to Gain Insight into Precursors and Polymerization of Proanthocyanidins in Plants (Under the direction of Dr. De-Yu Xie). Proanthocyanidins (PAs) are oligomers or polymers of flavan-3-ols. In plants, PAs have multiple protective functions against biotic and abiotic stresses. PAs are also important nutraceuticals existing in common beverages and food products to benefit human health. To date, although the biosynthesis of PAs has been intensively studieed and fundamental progress has been made in over the past decades, many questions remain unanswered. For example, its direct precursors of extension units are unknown and their monomer structure diversity are also unclear. These questions about proanthocyanidins result from not having of model systems and effective technologies. Our laboratory has made significant progress in enhancing the understanding of these unknown and unclear points regarding proanthocyanidins. In my dissertation research reported here, I focus on two areas: testing muscadine as a crop system to develop metabolomics for studying precursor diversity and isolating enzymes from a red cell tobacco system to understand the precursors of the extension units of PA. First, I developed a metabolomics protocol to analyze anthocyanidins and anthocyanins in muscadine grape. This study demonstrated that muscadine berries can produce at least six anthocyanidins, revealing the diversity of pathway precursors for PAs. The Journal of Agriculture and Food Chemistry is reviewing this work. Second, I developed a metabolomics protocol of HPLC-qTOF-MS/MS to analyze flavan- 3-ols and dimeric PAs in muscadine grape. This study also demonstrated the high structure diversity of flavan-3-ols, particularly methylated flavan-3-ols.
    [Show full text]
  • Interactions with Microbial Proteins Driving the Antibacterial Activity of Flavonoids
    pharmaceutics Review Interactions with Microbial Proteins Driving the Antibacterial Activity of Flavonoids Giuliana Donadio 1,†, Francesca Mensitieri 2,†, Valentina Santoro 1, Valentina Parisi 1,3, Maria Laura Bellone 1,3, Nunziatina De Tommasi 1, Viviana Izzo 2 and Fabrizio Dal Piaz 2,* 1 Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy; [email protected] (G.D.); [email protected] (V.S.); [email protected] (V.P.); [email protected] (M.L.B.); [email protected] (N.D.T.) 2 Department of Medicine and Surgery, University of Salerno, 84082 Baronissi, Italy; [email protected] (F.M.); [email protected] (V.I.) 3 PhD Program in Drug Discovery and Development, Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Flavonoids are among the most abundant natural bioactive compounds produced by plants. Many different activities have been reported for these secondary metabolites against numerous cells and systems. One of the most interesting is certainly the antimicrobial, which is stimulated through various molecular mechanisms. In fact, flavonoids are effective both in directly damaging the envelope of Gram-negative and Gram-positive bacteria but also by acting toward specific molecular targets essential for the survival of these microorganisms. The purpose of this paper is to present an overview of the most interesting results obtained in the research focused on the study of the Citation: Donadio, G.; Mensitieri, F.; interactions between flavonoids and bacterial proteins. Despite the great structural heterogeneity Santoro, V.; Parisi, V.; Bellone, M.L.; of these plant metabolites, it is interesting to observe that many flavonoids affect the same cellular De Tommasi, N.; Izzo, V.; Dal Piaz, F.
    [Show full text]
  • Purple Anthocyanin Colouration on Lower (Abaxial) Leaf Surface of Hemigraphis Colorata (Acanthaceae)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by NORA - Norwegian Open Research Archives Phytochemistry 105 (2014) 141–146 Contents lists available at ScienceDirect Phytochemistry journal homepage: www.elsevier.com/locate/phytochem Purple anthocyanin colouration on lower (abaxial) leaf surface of Hemigraphis colorata (Acanthaceae) Irene Skaar a, Christopher Adaku b, Monica Jordheim a, Robert Byamukama b, Bernard Kiremire b, ⇑ Øyvind M. Andersen a, a Department of Chemistry, University of Bergen, Allégt. 41, 5007 Bergen, Norway b Chemistry Department, Makerere University, P.O. Box 7062, Kampala, Uganda article info abstract Article history: The functional significance of anthocyanin colouration of lower (abaxial) leaf surfaces is not clear. Received 1 August 2013 Two anthocyanins, 5-O-methylcyanidin 3-O-(300-(b-glucuronopyranosyl)-b-glucopyranoside) (1) and Received in revised form 19 May 2014 5-O-methylcyanidin 3-O-b-glucopyranoside (2), were isolated from Hemigraphis colorata (Blume) Available online 20 June 2014 (Acanthaceae) leaves with strong purple abaxial colouration (2.2 and 0.6 mg/g fr. wt., respectively). The glycosyl moiety of 1, the disaccharide 300-(b-glucuronopyranosyl)-b-glucopyranoside), has previously Keywords: been reported to occur only in a triterpenoid saponin, lindernioside A. The structural assignment of Hemigraphis colorata the aglycone of 1 and 2 is the first complete characterisation of a natural 7-hydroxy-5-methoxyanthocy- Acanthaceae anidin. Compared to nearly all naturally occurring anthocyanidins, the 5-O-methylation of this anthocy- Abaxial leaf colouration Anthocyanins anidin limits the type of possible quinoidal forms of 1 and 2 to be those forms with keto-function in only 0 5-O-Methylcyanidin their 7- and 4 -positions.
    [Show full text]
  • Ep 3138585 A1
    (19) TZZ¥_¥_T (11) EP 3 138 585 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.03.2017 Bulletin 2017/10 A61L 27/20 (2006.01) A61L 27/54 (2006.01) A61L 27/52 (2006.01) (21) Application number: 16191450.2 (22) Date of filing: 13.01.2011 (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • Gousse, Cecile GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO 74230 Dingy Saint Clair (FR) PL PT RO RS SE SI SK SM TR • Lebreton, Pierre Designated Extension States: 74000 Annecy (FR) BA ME •Prost,Nicloas 69440 Mornant (FR) (30) Priority: 13.01.2010 US 687048 26.02.2010 US 714377 (74) Representative: Hoffmann Eitle 30.11.2010 US 956542 Patent- und Rechtsanwälte PartmbB Arabellastraße 30 (62) Document number(s) of the earlier application(s) in 81925 München (DE) accordance with Art. 76 EPC: 15178823.9 / 2 959 923 Remarks: 11709184.3 / 2 523 701 This application was filed on 29-09-2016 as a divisional application to the application mentioned (71) Applicant: Allergan Industrie, SAS under INID code 62. 74370 Pringy (FR) (54) STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES (57) The present specification generally relates to hydrogel compositions and methods of treating a soft tissue condition using such hydrogel compositions. EP 3 138 585 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 138 585 A1 Description CROSS REFERENCE 5 [0001] This patent application is a continuation-in-part of U.S.
    [Show full text]
  • ABSTRACT ZENG, HAINIAN. Development
    ABSTRACT ZENG, HAINIAN. Development-dependent Formation and Metabolism of Anthocyanins and Proanthocyanidins in Acer Species. (Under the direction of David Danehower, William Hoffmann, Jenny Xiang and De-yu Xie). Anthocyanins are one of the richest pigments, which belong to flavonoid compounds in plant kingdom. They have many biological and ecological functions. Over the past many years, numerous efforts have been made to determine the biosynthetic pathway of anthocyanins and also to identify several regulatory proteins mainly in flowers and fruits of model plants and crop plants. However, many questions concerning the metabolism of anthocyanins in foliage remains unsolved. One example is “How can developmental processes impact on accumulation patterns of anthocyanins in leaves”. In this study, we choose several cultivars from one of the most popular ornamental plants Acer palmatum Thunb. to understand the mechanism of developmental changes of pigmentation in leaf. Several other maple species were also analyzed. We propose that the metabolism of anthocyanins play an essential role in such changes. We use an integrated approach of phytochemistry and metabolic profiling to determine the biosynthesis and metabolism of anthocyanins and their impacts on foliage color. Proanthocyanidin analysis was carried out as well to determine their relationship to both anthocyanin production and foliar coloration. We have found that even for green leaves with no/trace amount of detectable anthocyanins, the biosynthetic pathway of anthocyanidin/proanthocyanidin
    [Show full text]
  • Anthocyanin Pigments: Beyond Aesthetics
    molecules Review Anthocyanin Pigments: Beyond Aesthetics , Bindhu Alappat * y and Jayaraj Alappat y Warde Academic Center, St. Xavier University, 3700 W 103rd St, Chicago, IL 60655, USA; [email protected] * Correspondence: [email protected] These authors contributed equally to this work. y Academic Editor: Pasquale Crupi Received: 29 September 2020; Accepted: 19 November 2020; Published: 24 November 2020 Abstract: Anthocyanins are polyphenol compounds that render various hues of pink, red, purple, and blue in flowers, vegetables, and fruits. Anthocyanins also play significant roles in plant propagation, ecophysiology, and plant defense mechanisms. Structurally, anthocyanins are anthocyanidins modified by sugars and acyl acids. Anthocyanin colors are susceptible to pH, light, temperatures, and metal ions. The stability of anthocyanins is controlled by various factors, including inter and intramolecular complexations. Chromatographic and spectrometric methods have been extensively used for the extraction, isolation, and identification of anthocyanins. Anthocyanins play a major role in the pharmaceutical; nutraceutical; and food coloring, flavoring, and preserving industries. Research in these areas has not satisfied the urge for natural and sustainable colors and supplemental products. The lability of anthocyanins under various formulated conditions is the primary reason for this delay. New gene editing technologies to modify anthocyanin structures in vivo and the structural modification of anthocyanin via semi-synthetic methods offer new opportunities in this area. This review focusses on the biogenetics of anthocyanins; their colors, structural modifications, and stability; their various applications in human health and welfare; and advances in the field. Keywords: anthocyanins; anthocyanidins; biogenetics; polyphenols; flavonoids; plant pigments; anthocyanin bioactivities 1. Introduction Anthocyanins are water soluble pigments that occur in most vascular plants.
    [Show full text]
  • Untargeted Metabolomics of Purple and Orange-Fleshed Sweet Potatoes
    www.nature.com/scientificreports OPEN Untargeted metabolomics of purple and orange‑feshed sweet potatoes reveals a large structural diversity of anthocyanins and favonoids Alexandra A. Bennett1,3,4, Elizabeth H. Mahood1,4, Kai Fan2 & Gaurav D. Moghe 1* Anthocyanins are economically valuable phytochemicals of signifcant relevance to human health. Industrially extracted from multiple fruit and vegetable sources, anthocyanin yield and profles can vary between sources and growing conditions. In this study, we focused on three purple‑feshed and one orange‑feshed cultivars of sweet potato—a warm‑weather, nutritious crop of substantial interest to growers in northern, cooler latitudes—to determine the yield and diversity of anthocyanins and favonoids. Acidifed ethanol extraction of lyophilized roots yielded ~ 800 mg average anthocyanins/100 g dry weight from all three cultivars. UHPLC‑DAD‑Orbitrap analysis of sweet potato extracts identifed 18 high‑confdence, mostly acylated peonidin and cyanidin derivatives contributing to > 90% of the total anthocyanin signal. Further assessment of the untargeted Liquid Chromatography–Tandem Mass Spectrometry data using deep learning and molecular networking identifed over 350 favonoid peaks with variable distributions in diferent sweet potato cultivars. These results provide a novel insight into anthocyanin content of purple‑feshed sweet potatoes grown in the northern latitudes, and reveal the large structural diversity of anthocyanins and favonoids in this popular crop. Anthocyanins are water-soluble phytochemical pigments of signifcant health and economic value, which belong to a class of polyphenolic compounds called favonoids. Found in many fruits and vegetables, favonoids possess antioxidant activities of beneft in managing ageing, stress, cancer and other health conditions, which makes them desirable for cosmetic, nutritional and health industry applications1–3.
    [Show full text]
  • Wo 2009/063333 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International Publication Number 22 May 2009 (22.05.2009) PCT WO 2009/063333 A2 (51) International Patent Classification: Not classified (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (21) International Application Number: AO, AT,AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, PCT/IB2008/003890 CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, (22) International Filing Date: IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, 14 November 2008 (14.1 1.2008) LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, (25) Filing Language: English RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (26) Publication Language: English ZW (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 60/987,866 14 November 2007 (14.1 1.2007) US GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, 61/037,191 17 March 2008 (17.03.2008) US ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), 12/270,23 1 13 November 2008 (13.11.2008) US European (AT,BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT,LU, LV,MC, MT, NL, (71) Applicant (for all designated States except US): OMNICA NO, PL, PT, RO, SE, SI, SK, TR), OAPI (BF, BJ, CF, CG, GMBH [DE/DE]; Plan 5, 20095 Hamburg (DE).
    [Show full text]